SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-022529
Filing Date
2017-04-10
Accepted
2017-04-10 16:02:42
Documents
3
Period of Report
2017-04-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-11119_18k.htm 8-K 53809
2 EX-10.1 a17-11119_1ex10d1.htm EX-10.1 199403
3 EX-10.2 a17-11119_1ex10d2.htm EX-10.2 171413
  Complete submission text file 0001104659-17-022529.txt   426061
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 441-295-5950
Axovant Sciences Ltd. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37418 | Film No.: 17753427
SIC: 2834 Pharmaceutical Preparations